Suppr超能文献

口服阿普唑仑和劳拉西泮作为催眠药对高血压患者心血管参数的影响。

Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive Patients.

机构信息

Internal Medicine and Therapeutics, University of Pavia.

出版信息

J Clin Psychopharmacol. 2021;41(2):191-195. doi: 10.1097/JCP.0000000000001362.

Abstract

BACKGROUND

Previous studies have suggested that evening intake of benzodiazepine affects blood pressure (BP) and/or heart rate (HR) in healthy and hypertensive subjects. The aim of this study was to compare the effect of chronic oral administration of alprazolam and lorazepam as hypnotics on ambulatory BP and HR in patients with mild hypertension.

METHODS

Consecutive outpatients of both sexes with newly diagnosed, never-treated mild hypertension were randomized, after a 4-week placebo run-in period, to receive alprazolam 0.5 mg plus placebo, lorazepam 1 mg plus placebo, or placebo plus placebo for 2 weeks in 3 crossover periods, each separated by a 1-week placebo wash-out period. At the end of the initial placebo run-in and of each treatment period, 24-hour ambulatory BP and HR monitoring was performed using a noninvasive device.

RESULTS

In the 32 patients, no treatment had any effect on 24-hour and daytime systolic BP (SBP), diastolic BP (DBP), and HR, which remained unchanged. During the nighttime, SBP and DBP values were unaffected by alprazolam, as compared with placebo, whereas DBP was significantly higher after treatment with lorazepam (+3.7%, P < 0.05 vs placebo). Nocturnal HR mean values were significantly increased by lorazepam (+10.1%, P < 0.01 vs placebo), whereas they did not change after alprazolam.

CONCLUSIONS

In patients with mild hypertension, oral intake of alprazolam or lorazepam as hypnotics did not affect ambulatory BP or HR values. A slight increase in nighttime DBP was observed with lorazepam, whereas alprazolam showed no effect on nocturnal BP and HR, probably reflecting a stimulating effect of the drug on central α2-receptors.

摘要

背景

之前的研究表明,苯二氮䓬类药物在晚间摄入会影响健康人群和高血压人群的血压(BP)和/或心率(HR)。本研究旨在比较慢性口服阿普唑仑和劳拉西泮作为催眠药对轻度高血压患者的动态血压和心率的影响。

方法

连续入选新诊断的、未经治疗的轻度高血压的男女患者,在 4 周安慰剂洗脱期后,随机接受阿普唑仑 0.5mg+安慰剂、劳拉西泮 1mg+安慰剂或安慰剂+安慰剂治疗 2 周,每个周期之间间隔 1 周的安慰剂洗脱期。在初始安慰剂洗脱期和每个治疗期结束时,使用非侵入性设备进行 24 小时动态血压和心率监测。

结果

在 32 名患者中,治疗对 24 小时和白天的收缩压(SBP)、舒张压(DBP)和心率没有任何影响,这些参数保持不变。在夜间,与安慰剂相比,阿普唑仑对 SBP 没有影响,但劳拉西泮治疗后 DBP 显著升高(+3.7%,P<0.05 与安慰剂相比)。劳拉西泮可显著增加夜间 HR 平均值(+10.1%,P<0.01 与安慰剂相比),而阿普唑仑则无变化。

结论

在轻度高血压患者中,口服阿普唑仑或劳拉西泮作为催眠药不会影响动态血压或心率值。劳拉西泮可观察到夜间 DBP 轻度升高,而阿普唑仑对夜间 BP 和 HR 无影响,这可能反映了药物对中枢 α2-受体的刺激作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验